Inlita coated tablets 1 mg. №56

$1,237.00

Manufacturer: Germany

Treatment of advanced renal cell carcinoma if the previous course of systemic treatment was ineffective.

Category:

Description

Inlita Composition

The drug contains the active ingredient axitinib. You can buy the substance in one of two dosages of 1 mg or 5 mg. The composition also includes additional components: cellulose, lactose, monohydrate, magnesium stearate. To improve the effect on the body, the dosage form of film-coated tablets has been selected.

Inlita Indications

The main indication in which this pharmaceutical preparation is used is renal cell adenocarcinoma of the common type, if standard therapy does not give the desired result. With a detailed study of the effect of the presented drug, it was found that it has hepatotoxic and nephrotoxic effects, therefore, when prescribing therapy with this substance, it is necessary to monitor the general health and conduct a constant biochemical blood test.

Despite the fact that Inlita 1 mg No. 56 the price is at the level with other similar drugs, it performs its function and in most cases helps to stop the progression of the disease, up to the onset of a stable remission. The price can be clarified by studying the description of this medication.

Inlita Contraindications

The use of the drug should be canceled in a number of conditions, which are indicated by reviews and clinical studies:

patients’ age up to 18 years;

the state of pregnancy;

lactation period;

the emergence of an individual reaction to individual components of the drug.

Application and doses

When starting to use the drug, a dose of 5 mg is recommended, taken 2 times a day. To maintain the concentration of the substance in the blood plasma, an interval of 12 hours must be observed. The intake of this drug does not depend on the diet. You need to drink the pill whole with a glass of water. If it was not possible to take the prescribed dosage on time, the next dose must be taken at the specified time without an additional dose.

It is possible to increase the dosage only if the patient has good tolerance to the drug for more than 2 weeks from the start of therapy. Then an adjustment of up to 7 mg is allowed. The maximum dose can be increased up to 10 mg. Dosage reduction occurs in the event of intolerance and adverse reactions.